Matarin Capital Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-49,974
| Closed | -$4.17M | – | 239 |
|
|
2016
Q2 | $4.17M | Buy |
49,974
+5,030
| +11% | +$420K | 0.57% | 75 |
|
|
2016
Q1 | $4.13M | Buy |
44,944
+3,895
| +9% | +$358K | 0.58% | 74 |
|
|
2015
Q4 | $4.15M | Buy |
41,049
+29,477
| +255% | +$2.98M | 0.62% | 74 |
|
|
2015
Q3 | $1.14M | Sell |
11,572
-6,661
| -37% | -$654K | 0.23% | 129 |
|
|
2015
Q2 | $2.13M | Hold |
18,233
| – | – | 0.61% | 71 |
|
|
2015
Q1 | $1.79M | Buy |
18,233
+3,356
| +23% | +$329K | 0.54% | 93 |
|
|
2014
Q4 | $1.4M | Buy |
14,877
+458
| +3% | +$43.2K | 0.62% | 80 |
|
|
2014
Q3 | $1.53M | Sell |
14,419
-652
| -4% | -$69.4K | 0.7% | 71 |
|
|
2014
Q2 | $1.25M | Buy |
15,071
+6,130
| +69% | +$508K | 0.56% | 82 |
|
|
2014
Q1 | $634K | Buy |
+8,941
| New | +$634K | 0.37% | 101 |
|
|
2013
Q4 | – | Sell |
-10,199
| Closed | -$641K | – | 135 |
|
|
2013
Q3 | $641K | Sell |
10,199
-1,213
| -11% | -$76.2K | 0.54% | 77 |
|
|
2013
Q2 | $585K | Buy |
+11,412
| New | +$585K | 0.59% | 68 |
|